US FDA | Symposium Highlights Advancements in Continuous Manufacturing and Nanotechnology | October 11, 2023
The FDA recently held a symposium focusing on continuous manufacturing technologies and nanomaterials in the pharmaceutical industry. During the event, the FDA shared insights into its experiences with approving various solid oral drug products that have leveraged continuous manufacturing methods.
Key highlights included the presentation of case studies showcasing both intramural and extramural research efforts in the fields of nanomaterials and continuous manufacturing. These case studies aimed to inspire innovation and wider adoption of continuous manufacturing techniques within the pharmaceutical sector.
Moreover, the symposium addressed collaborative opportunities for industry, academia, and regulatory agencies to work together with the FDA in advancing nanotechnology and continuous manufacturing. This event underlined the importance of cooperation in driving progress in these crucial areas of pharmaceutical development.
MORE INFO ON www.natlawreview.com